“Precision Reprogramming of Lung Cancer Biomarkers via CRISPR/Cas9: A Paradigm Shift in Personalized Immunotherapy” (2025) Journal of Analytical Oncology, 14, pp. 96–105. doi:10.30683/1927-7229.2025.14.15.